发明公开
EP2046386A2 PEPTIDE COMPOUNDS FOR THE TREATMENT OF HYPEREXCITABILITY DISORDERS AND DISEASES ASSOCIATED WITH ION CHANNEL DYSFUNCTION 有权
肽化合物骨骼肌疾病作者对离子通道功能障碍连接处理

  • 专利标题: PEPTIDE COMPOUNDS FOR THE TREATMENT OF HYPEREXCITABILITY DISORDERS AND DISEASES ASSOCIATED WITH ION CHANNEL DYSFUNCTION
  • 专利标题(中): 肽化合物骨骼肌疾病作者对离子通道功能障碍连接处理
  • 申请号: EP07764967.1
    申请日: 2007-06-29
  • 公开(公告)号: EP2046386A2
    公开(公告)日: 2009-04-15
  • 发明人: HEERS, CaraSTÖHR, ThomasBEYREUTHER, Bettina
  • 申请人: SCHWARZ PHARMA AG
  • 申请人地址: Alfred-Nobel-Strasse 10 40789 Monheim DE
  • 专利权人: SCHWARZ PHARMA AG
  • 当前专利权人: SCHWARZ PHARMA AG
  • 当前专利权人地址: Alfred-Nobel-Strasse 10 40789 Monheim DE
  • 代理机构: Weiss, Wolfgang
  • 优先权: EP06013655 20060630; EP06021469 20061012; EP06021470 20061012; EP06024241 20061122
  • 国际公布: WO2008000513 20080103
  • 主分类号: A61K45/06
  • IPC分类号: A61K45/06 A61K38/04 A61K31/55 A61P25/00
PEPTIDE COMPOUNDS FOR THE TREATMENT OF HYPEREXCITABILITY DISORDERS AND DISEASES ASSOCIATED WITH ION CHANNEL DYSFUNCTION
摘要:
The present invention is directed to the use of a class of peptide compounds for treating diseases associated with dysfunction of an ion channel.
信息查询
0/0